Search

everythinglearnresearchcommunity

for

Search:↓

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Lower ghrelin levels and certain gene variations may increase acne risk.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Effective, well-tolerated, and affordable treatments are needed for recurrent ischemic priapism.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Diagnosing PCOS in teenage girls is tricky and requires careful evaluation and management.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

PCOS is a major cause of infertility and requires personalized treatment.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.